Protagenic Therapeutics I...

0.28
-0.02 (-8.20%)
At close: Mar 03, 2025, 3:59 PM
0.50
81.32%
After-hours: Mar 03, 2025, 07:59 PM EST

Protagenic Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95
Net Income -5M -3.56M -4.52M -2.55M -1.75M -2.56M -2.26M -2.28M -476K -1.08M -1.03M -19.73M -29.44M -115.77M -4.15M 677K -94.47K -1.33M -7.9M -728K 144K 1.14M -674K 648K -858K -500K -800K
Depreciation & Amortization 28.22K 30.00 427.14K 286.00 339.00 347.00 148.00 534.00 1K 0.38 1.20 1.64M 3.7M 5.87M 1.35M 25K n/a n/a 2.49M 2.09M 2.03M 1.89M 1.91M 1.55M 1.12M 1.05M 1.1M
Stock-Based Compensation 666.83K 864.68K 1.52M 1.65M 797.76K 1.13M 888.28K 546.13K 478.63 275K 603.78 1.11M 857K 1.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -87.09K 631.73K -480.51K -361.43K 602.66K 11.14K -34.13K -54.19K 74K 93K 995K 1.03M -6.96M -2.08M -1.96M 373K n/a n/a -6.88M 735K -57K 52K -537K -1.54M -1.16M 1.31M -920K
Other Non-Cash Items 716.09K 156.85K 345.95K 154.9K 110.91K 246.19K 99.78K 150K -7K -46K 106.74 4.81M 19.44M 116.07M 419K 375K n/a 485K 10.85M n/a n/a n/a n/a 174K 150K -470K 20K
Deferred Income Tax n/a n/a -427.14K -248.55K -348.29K n/a -91.8K 440.78K n/a n/a n/a -1.54M 3.65M -2.35M -1.15M 183K n/a n/a n/a n/a -241K n/a n/a n/a n/a n/a n/a
Change in Working Capital -114.41K 540.13K -140.39K -361.43K 702.2K 109.73K -16.87K -1.94K 104K 60K 703K 2.45M -1.22M -752K -1.96M -329K 50.47K n/a -3.57M 980K -426K 482K -907K -2.8M -2.62M -310K -920K
Operating Cash Flow -3.7M -1.99M -2.8M -1.35M -487.99K -1.07M -1.38M -1.14M -378K -790K -324K -11.25M -3.02M 4.36M -5.21M 931K -44K -842K 1.87M 2.35M 1.5M 3.51M 331K -434K -2.2M -230K -600K
Capital Expenditures -149.78K -1.8K n/a n/a n/a n/a n/a n/a -1K -1K n/a -41K -682K -2.03M -266K -77K n/a n/a -1.48M -1.78M -3.79M -3.23M -81K -65K -2.86M -1.42M -1.33M
Acquisitions n/a 46.05K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.74M 4.18M -970K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -2.76M -34.12K -10.4M n/a n/a -2.74M -3.43M n/a n/a n/a n/a n/a -914K -9.1M -3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 7.69M 1.63M 485.95K n/a 250K 3.79M 2.15M n/a n/a n/a n/a 720K 6.18M 24.71M 100K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -46.05K -9.91K n/a 250.00 1.05K -1.29K n/a n/a 15K 15K n/a -480K n/a -1.05M -123K n/a 6.43M n/a n/a 1.84M 1.57M -1.73M -3.67M 1.4M n/a n/a
Investing Cash Flow 4.78M 1.6M -9.91M n/a 250K 1.05M -1.29M n/a -1K -1K 15K 679K 2.37M 17.77M -5.18M -200K n/a 6.43M -1.48M -1.78M -1.95M -1.66M -1.81M -3.73M -1.46M -1.42M -1.33M
Debt Repayment n/a n/a n/a 1.33M 670K n/a n/a 19K 340K 175K n/a n/a -1.75M -111K -587K -324K 14K n/a n/a -604K 482K 764K n/a 3.88M -3.24M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -100 -9K -939K -4.05M n/a n/a n/a n/a n/a n/a -20K -967K n/a n/a n/a n/a 1.5M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a 869.63K -104.09K n/a n/a n/a 8.52M n/a n/a 31K n/a -150K 1.36M -469K -213K 30K n/a -300K -9K n/a -1.77M 1.58M n/a n/a 1.24M 2.1M
Financial Cash Flow n/a n/a 12.58M 1.22M 670K n/a n/a 4.28M 340K 175K 31K -9K -2.84M -2.8M 17.46M -537K 44K n/a -300K -568K 462K -1.98M 1.58M 3.88M 3.85M 1.24M 2.1M
Net Cash Flow 1.07M -325.98K -129.92K -127.53K 436.14K -37.2K -2.7M 3.1M -39K -616K -278K -10.59M -3.5M 19.3M 7.07M 194K n/a 4.42M 90K -5K 16K -133K 99K -289K 189K -400K 170K
Free Cash Flow -3.85M -2M -2.8M -1.35M -487.99K -1.07M -1.38M -1.14M -379K -791K -324K -11.29M -3.7M 2.33M -5.48M 854K -44K -842K 390K 563K -2.29M 278K 250K -499K -5.06M -1.65M -1.93M